---

$8.18

-0.1560 ( -1.87% ) 74.3K

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2025-08-21	Buy	15000.00	Wills Robert James
2025-08-21	Buy	15000.00	Wills Robert James
2025-08-20	Buy	27778.00	MERTZ LEONARD POWELL
2024-11-15	Buy	4347.00	HAVENS JOHN PRENTISS
2024-11-15	Buy	8695.00	MERTZ LEONARD POWELL
2024-11-15	Buy	2608.00	McFadden Michael E.